Factors increasing the risk of allograft vascular disease in heart transplant recipients

Giornale Italiano di Cardiologia

Volumn 27, Issue 10, 1997, Pages 985-999

  Arbustini, Eloisa ^a   Bello, Barbara Dal ^b   Morbini, Patrizia ^a   Klersy, Catherine ^a   Grasso, Maurizia ^a   Diegoli, Marta ^a   Gavazzi, Antonello ^c   Campana, Carlo ^a   Grossi, Paolo ^d   Pellegrini, Carlo ^b   Martinelli, Luigi ^a   Ippoliti, Gianbattista ^a   Specchia, Giuseppe ^a   Viganö, Mario ^a  

^a Dept of Pathology ^*

^b Biometrie Unit Scientific Direction

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d Istituto di Anatomia Patologica Wa Forlanini   (Italy)

Author keywords

Allograft vascular disease; Heart transplantation

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; ATHEROSCLEROSIS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HEART DILATATION; HEART TRANSPLANTATION; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; RISK FACTOR;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; CYTOMEGALOVIRUS INFECTIONS; DATA INTERPRETATION, STATISTICAL; FEMALE; GRAFT REJECTION; HEART DISEASES; HEART TRANSPLANTATION; HEPATITIS C; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; POISSON DISTRIBUTION; REOPERATION; RISK FACTORS; TIME FACTORS; VASCULAR DISEASES;

EID: 9844253333     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. HOSENPUD JD, NOVICK RJ, BENNETT LE, KECK BM, FIOL B, DAILY P: The Registry of the International Society for Heart and Lung Transplantation: Thirteenth Official Report - 1996. J Heart Lung Transplant 1996; 15: 655-674.
2. HOSENPUD JD, NOVICK RJ, BREEN TJ, KECK B, DAILY P: The Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Report - 1995. J Heart Lung Transplant 1995; 14: 805-815.
3. KAYE MP: The Registry of the International Society for Heart and Lung Transplantation: Tenth Official Report - 1993. J Heart Lung Transplant 1993; 12: 541-548.
4. BILUNGHAM ME: Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterat/Ve bronchiolitis. Transplant Proc 1995; 27: 2013-2016.
5. BlLUNGHAM ME: Histopathology of graft coronary disease. J Heart Transplant 1992; 11: S38-S44.
6. ARBUSTINI E, ROBERTS WC: Morphologic observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease]. Am J Cardiol 1996; 78: 814-820.
7. ARBUSTINI E, DAL BELLO B, MORBINI P, ET AL: Frequency and characteristics of coronary thrombosis in the epicardial coronary arteries after cardiac transplantation. Am J Cardiol 1996; 78: 795-800.
8. Pucci AM, FORBES RDC, BILLINGHAM ME: Pathologic features in long-term cardiac allografts. J Heart Transplant 1990; 9: 339-345.
9. RICKENBACHER PR, KEMNA MS, PINTO FJ, ET AL: Coronary artery intimai thickening in the transplanted heart. An in vivo intracoronary ultrasound study of immunologie and metabolic risk factor. Transplantation 1996; 61: 46-53.
10. RICKENBACHER PR, PINTO FJ, LEWIS NP, ET AL: Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography. Am J Cardiol 1995; 76: 340-345.
11. On GY, HERSCHBERGER RE, RATKOVEC RR, NORMAN D, HOSENPUD JD, COBANOGLU A: Cardiac allografts from high-risk donors: excellent clinical results. Ann Thorac Surg 1994; 57: 76-82.
12. JOHNSON MR: Transplant coronary disease: nonimmuno/ogic risk factor. J Heart Lung Transplant 1992; 11: S124-S132.
13. MEHRA MR, STAPLETON DD, VENTURA HO, ET AL: Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study. Circulation 1994; 90 (Suppl II): 78-82.
14. WAU.woRK J: Risk factors for chronic rejection in heart and lungs. Why do hearts and lungs rot? Clin Transplantation 1994; 8: 341-344.
15. BRIGANTI EM, BERGIN PJ, ROSENFELDT FL, ESMORE DS, RABINOV M: Successful long-term outcome with prolonged ischémie time. J Heart Lung Transplant 1995; 14: 840-845.
16. REED EF, HONG E, HARRIS PE, WEINBERGER J, Suciu FOCA N: Monitoring of soluble alloant/gens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 1996; 61: 566-572.
17. HOSENPUD JD, EVERETT JP, MORRIS TE, MAUCK KA, SHIPLEY GD, WAGNER CR: Cardiac allograh vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995; 92: 205-211.
18. COSTANZO-NORDIN MR: Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant 1992; 11: S90-S103.
19. STEMPFLE HU, MUDRA H, STROM C, ET AL: Influence of HLA compatibility on the incidence of cardiac allograft vasculopathy after heart transplantation. Transplant Proc 1995; 27: 1977-1978.
20. GAO SZ, HUNT SA, SCHROEDER JS, ALDERMAN EL, HILL IR, STINSON EB: Early development of accelerated graft coronary artery disease. J Am Coll Cardiol 1996; 28: 673-679.
21. McGiFFiN DC, SAVUNEN T, KIRKUN JK, ET AL: Cardiac transplant coronary artery disease. A multivariate analysis of pretransplantation risk factors for disease development and morbid events. J Thorac Cardiovasc Surg 1995; 109: 1081-1088.
22. KOSKINEN PK, NlEMINEN MS, KROGERUS LA, ET AL: Cytomegalovirus infection and accelerated cardiac allograh vasculopathy in human cardiac allografts. J Heart Lung Transplant 1993; 12: 724-729.
23. MEHRA MR, VENTURA HO, STAPLETON DD, SMART FW, COUJNS TC, RAMEE SR: Presence of severe intimai thickening by intravascular" ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant 1995; 14: 632-639.
24. GAO SZ, SCHROEDER JS, HUNT SA, VALANTINE HA, HILL IR, STINSON EB: Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant 1993; 12: 1029-1035.
25. FUJITA M, RüSSEL ME, MASEK MA, ROWAN R, NAGASHIMA K, BiLLINGHAM ME: Graft vascular disease in the great vessels and vasa vasorum. Hum Pathol 1993; 24: 1067-1072.
26. MILLER L, KOBASHIGAWA J, VALANTINE H, ET AL: The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. J Heart Lung Transplant 1995; 14: S227-S234.
27. HAVERICH A, COSTARD-JACKLE A, CREMER J, HERRMANN G, SIMON R: Cyclosporin A and transplant coronary disease after heart transplantation: facts and fiction. Transplant Proc 1994; 26: 2713-2715.
28. ARBUSTINI E, GRASSO M, DIEGOU M, ET AL: La biopsia endomiocardica: stato dell'arte. G Ital Cardiol 1991; 21: 97-113.
29. ARBUSTINI E, DAL BELLO B, RINALDI M, ET AL: Acute rejection and heart infection rates in FK506-versus cyclosporine A-treated heart transplanted patients. J Heart Lung Transplant 1997, in press.
30. GROSSI P, DE MARIA R, CAROU A, ET AL: Infections in heart transplant recipients: the experience of the Italian Heart Transplantation Program. J Heart Transplant 1992; 11: 847-866.
31. ARBUSTINI E, GRASSO M, DIEGOU M, ET AL: Histopathological and molecular profile of human Cytomegalovirus infection in heart transplanted patients. Am J Clin Pathol 1992; 98: 205-213.
32. GROSSI P, MiNOU L, PERCIVALLE E, IRISH W, VIGANô M, GERNA G: Clinical and monitoring of human Cytomegalovirus infection in 294 heart transplant recipients. Transplantation 1995; 59: 847-851.
33. BILLINGHAM ME, CARY NRB, HAMMOND ME, ET AL: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 587-593.
34. ARBUSTINI E, GRASSO M, DIEGOU M, ET AL: Expression of tumors necrosis factor in human cardiac acute rejection. An immunohistochemical and immunoblotting study. Am J Pathol 1991; 139: 709-715.
35. TERASAKI PI, BERNOCO P, PARKS MS, ET AL: Microdroplet testing for HLA A, B, C and D antigens. Am J Clin Pathol 1978; 69: 103-120.
36. TERASAKI PI, TAKEMOTO S, PARKS MS, CECKA JM, MICKEY MR: Molecular HLA matching. Transplant Proc 1991; 23: 365-367.
37. CLAYTON D, HILLS M: Statistical models in epidemiology. Oxford, Oxford University Press, 1993.
38. EVERETT JP, HERSHBERGER RE, NORMAN DJ, ET AL: Prolonged Cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992; 11: S133-S137.
39. BRAUNUN EA, HUNTER DW, CANTER CE, ET AL: Coronary artery disease in pédiatrie cardiac transplant recipients receiving triple-drug immunosuppression. Circulation 1991; 84 (Suppl III): 303-309.
40. STOVIN PGI, SHARPLES L, HUTTER JA, WALLWORK J, ENGLISH TAH: Some prognostic factors for the development of transplant-related coronary artery disease in human cardiac allografts. J Heart Lung Tranplant 1991; 10: 38-44.
41. LOEBE M, SCHULER S, ZAIS 0, WARNECKE H, FLECK E, HETZER R: Role of Cytomegalovirus infection in the development of coronary artery disease in transplanted heart. J Heart Transplant 1990; 9: 707-711.
42. GUUZIA JM, KANDOLF R, KENDALL TJ, ET AL: Infrequency of Cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 1995; 147: 461-475.
43. LE BIDOIS J, LADEIA A, VOUHE P, ET AL: Facteurs de risque de la maladie coronaire du greffon après transplantation cardiaque de l'enfant. Arch Mal Coeur Vaiss 1994; 86: 587-591.
44. SHARPLES LD, CAINE N, MULUNS P, ET AL: Risk factor analysis for the major hazards following heart transplantation. Rejection, infection, and coronary occlusive disease. Transplantation 1991; 52: 244-252.
45. MCMURRAY RW, ELBOURNE K: Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheuma 1997; 26:" 689-701.
46. RADOVANCEVIC B, POINDEXTER S, BIROVUJEV S, ET AI: Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardio-thorac Surg 1990; 4: 309-313.
47. SCHUTZ A, KEMKES BM, KUGLER C, ET AL: The influence of rejection episodes on the development of coronary artery disease after heart transp/antation. Eur J Cardio-thorac Surg 1990; 4: 300-308.
48. EICH D, THOMPSON JA, Ko D, ET AL: Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant 1991; 10: 45-49.
49. OPELZ G, WUJCIAK T: The influence of HLA compatibility on graft survival after heart transplantation. N Engl J Med 1994; 330: 816-819.
50. COCANOUGHER B, BALLANTYNE CM, POLLACK MS, ET AL: Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. Transplant P 1993; 25: 233-236.
51. KERMAN RH, KIMBALL P, SCHEINEN S, ET AL: The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients. Transplantation 1994; 57: 884-888.
52. JUTTE NHPM, GROENEVELD K, BALK AHMM, ET AL: The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures. Clin Exp Immunol 1994; 98: 158-162.
53. ZERBE T, URETSKY B, KORMOS R, ET AL: Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant 1992; 11: S104-S110.
54. ADDONIZIO U, Hsu DT, DOUGLAS JF, ET AL: Decreasing incidence of coronary artery disease in pédiatrie cardiac transplant recipients using increased immunosuppression. Circulation 1993; 88: 224-229.
55. STOVIN PGI, SHARPLES LD, SCHOFIELD PM, ET AL: Lack of association between endomyocardial evidence of rejection in the first six-months and the later development of transplant-related coronary artery disease. J Heart Lung Tranplant 1993; 12: 110-116.
56. DRINKWATER DC, RUDIS E, LACKS H, ET AL: University of Wisconsin solution versus Stanford cardioplegic solution and the development of cardiac allograft vasculopathy. J Heart Lung Transplant 1995; 14: 891-896.
57. RICKENBACHER PR, PINTO FJ, LEWIS NP, ET AL: Prognostic importance of intimai thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation 1995; 92: 3445-3452.
58. DE LORGERIL M, BOISSONNAT P, MAMELLE N, ET AL: Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation 1994; 89: 2590-2594.
59. DüNN MJ, CRISP SJ, ROSE ML, TAYLOR PM, YACOUB MH: Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339: 1566-1570.
60. YOUNG JB, WINDSOR NT, KLEIMAN NS, LOWRY R, COCANOUGHER B, LAWRENCE EC: The relationship of soluble interleukin-2 receptor levels to allograft arteriopathy after heart transplantation. J Heart Lung Transplant 1992; 11: S79-S82.
61. BARBIR M, BANNER N, THOMPSON GR, KHAGHANI A, MITCHELL A, YACOUB M: Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart. Int J Cardiol 1991; 32: 51-56.
62. DAVIES H, VERNEY G, ENGLISH T: The coronary arteries of the transplanted human heart: studies of the development of disease based on serial angiography. IntJCardiol 1991; 32: 35-50.
63. CARRIER M, PELLETIER G, LECLERC G, ET AL: Accelerated coronary atherosclerosis after cardiac transplantation: major threat to long-term survival. Can J Surg 1991; 34: 133-136.